HealthPhoto: Mint CompaniesPopVax Starts Human Trials of Fridge-Stable Covid Vaccine
Hyderabad-based biotech startup PopVax has initiated human trials for an RNA-based covid-19 vaccine candidate that remains stable at refrigerator temperatures for at least nine months. This stability could simplify vaccine distribution in countries lacking advanced cold-chain infrastructure, potentially improving access and logistics for immunization efforts.
Mint Companies··Hyderabad




